High-intensity interval training makes middle-aged people not only healthier but smarter, showed a Montreal Heart Institute (MHI) study led by Dr. Anil Nigam of the MHI and University of Montreal, in collaboration with the Montreal Geriatric University Institute. The participants all had a body-mass index (BMI) between 28 and 31 (overweight) in addition to one or more other cardiovascular risk factors.
Today, the preliminary results of a Canadian study on the testing of a new percutaneous mitral valve at the Montreal Heart Institute (MHI) were presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, the world's largest meeting in vascular medicine, which is taking place this year in Miami, Florida.
Dr. John D. Rioux, researcher at the Montreal Heart Institute (MHI) and Associate Professor of Medicine at the Université de Montréal, has been awarded $ 1.8M from the prestigious US National Institutes of Health (NIH) in support of his research of the chronic inflammatory bowel diseases (IBD) known as Crohn’s disease (CD) and ulcerative colitis (UC), affecting 1 in 150 Canadians.
A team of cardiologists from the Montreal Heart Institute (MHI) specializing in cardiac arrhythmias has used for the very first time in Canada, a technology developed in Montreal to treat a patient with atrial fibrillation. Recently licenced by Health Canada, this sophisticated device is a balloon inserted by catheter that uses extreme cold to burn malfunctioning heart tissue.
The surgical team at the Montreal Heart Institute (MHI) achieved a North American surgical milestone on May 1st with a sutureless aortic valve replacement through a thoracic incision just five centimetres long. The two patients in their seventies who underwent this innovative procedure, which was performed by cardiac surgeons Denis Bouchard and Michel Carrier, were doing well only one week after their operations.
In the presence of Mr. Sam Hamad, Quebec Minister of Economic Development, Innovation & Export Trade and Minister responsible for the Capitale-Nationale region, the Montreal Heart Institute (MHI) was designated today as the hub for translational medicine studying cardiometabolic disease in the global network of the multinational pharmaceutical company Roche.
The Montreal Heart Institute (MHI) congratulates Dr. Paul Khairy, cardiologist-electrophysiologist and Director of the Adult Congenital Heart Centre at the MHI, on his appointment as president of the International Society for Adult Congenital Heart Disease (ISACHD). His appointment was announced yesterday at the meeting of the American College of Cardiology that is currently taking place in Chicago.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.